News Column

BIO Statement on World Health Organization Proposed International Nonproprietary Naming (INN) Policy for Biologic Medicines

July 31, 2014

WASHINGTON, July 31 -- The Biotechnology Industry Organization issued the following news release:

The following statement may be attributed to BIO President and CEO Jim Greenwood:

"BIO played a leading role in the effort to establish a pathway for the approval of biosimilars in the United States and believes that their introduction into the marketplace is important for patients. Biosimilars, however, raise novel and complex questions of science and law that require the updating of legal and regulatory frameworks to ensure, among other things, accurate product identification. We applaud the World Health Organization (WHO) for recognizing this need by issuing "Biological Qualifier: An INN Proposal," and we strongly support its intent to ensure that all biological medicines are distinguishable. We appreciate the WHO's willingness to consider additional stakeholder input as to how best to effectuate this shared goal, and we look forward to providing detailed comments on the proposal."

Upcoming BIO Events

BIO Latin America Conference

September 9-11, 2014

Rio de Janeiro, Brazil

Livestock Biotech Summit

September 16-18, 2014

Sioux Falls, SD

BIO Investor Forum

October 7-8, 2014

San Francisco, CA

Pacific Rim Summit on Industrial Biotechnology & Bioenergy

December 7-9, 2014

San Diego, CA

BIO International Convention

June 15-18, 2015

Philadelphia, PA

[Category: Science]

TNS 24HariCha-140801-30FurigayJane-4816616 30FurigayJane

For more stories covering the world of technology, please see HispanicBusiness' Tech Channel

Source: Targeted News Service

Story Tools Facebook Linkedin Twitter RSS Feed Email Alerts & Newsletters